Market Overview

Morning Market Movers

Related NBIX
6 Stocks That Plummeted The Past Three Days On Increasing Volume
Benzinga's Top Initiations
Investigational Endometriosis Therapy Elagolix May Transform Neurocrine Biosciences' Future Fortunes (Seeking Alpha)
Related EPZM
Good And Bad News from Epizyme; Wedbush Analyst Weighs In
A Peek Into The Markets: U.S. Stock Futures Signal Lower Start On Wall Street

Neurocrine Biosciences (NASDAQ: NBIX) jumped 60.40% to $15.66 after the company reported positive results of VMAT2 inhibitor NBI-98854 in Kinect 2 study.

Epizyme (NASDAQ: EPZM) moved up 55.32% to $31.84 after the company reported two major milestone achievements. It announced the achievement of a proof of concept milestone in the EPZ-5676 DOT1L inhibitor clinical program.

Verso Paper (NYSE: VRS) rose 31.70% to $4.23 after the company announced its plans to acquire NewPage for $1.4 billion.

Stereotaxis (NASDAQ: STXS) shares jumped 19.26% to $4.77 after the company Stereotaxis completed the clinical trial of Vdrive with V-Loop.

Posted-In: market moversNews Intraday Update Markets Movers


Related Articles (NBIX + EPZM)

View Comments and Join the Discussion!